Sort
23,748 grants matching “melanoma”
Mechanisms of racial disparity in breast cancer-related lymphedema
$697,823Babak J Mehrara · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer
$697,752Ryan Bruce Corcoran · Massachusetts General Hospital · R01 · FY2023 · CA
Identification of Covalent Transcriptional Dependencies in Melanoma
$697,629Liron Bar-Peled · Massachusetts General Hospital · R01 · FY2024 · CA
THE FRAMINGHAM SCHOOL STUDY OF NEVI IN CHILDREN SONIC II
$697,614Allan C Halpern · Sloan-Kettering Inst Can Research · R01 · FY2012 · AR
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
$697,539Anna Karolina Palucka · Jackson Laboratory · R01 · FY2017 · CA
Circulating Vitamin D Levels and Risk of Breast and Colorectal Cancer: a Pooled A
$697,412Stephanie A Smith-Warner · Harvard School Of Public Health · R01 · FY2010 · CA
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
$697,267Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
$697,232Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
$697,166Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Development of Novel Inhibitors of Ganglioside Biosynthesis
$697,057Brett E Crawford · Zacharon Pharmaceuticals, Inc. · R44 · FY2008 · CA
Cancer Deep Phenotype Extraction from Electronic Medical Records
$696,805Rebecca S Crowley · University Of Pittsburgh At Pittsburgh · U24 · FY2014 · CA
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
$696,769Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells
$696,509Carl D Novina · Dana-Farber Cancer Inst · R01 · FY2016 · CA
ISIC-REPO; ISICâ¯Skin Imagingâ¯Repository Enhancements for Promoting Interoperability and Utilization
$696,147Allan C Halpern · Sloan-Kettering Inst Can Research · U24 · FY2025 · CA
Skin Disease Research Center
$695,661Thomas S. Kupper · Brigham And Women'S Hospital · P30 · FY2006 · AR
Skin Disease Research Center
$695,661Brigham And Women'S Hospital · P30 · FY2005 · AR
Role of GPNMB in cardiac remodeling
$695,652Arjun Deb · University Of California Los Angeles · R01 · FY2022 · HL
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
$695,333Katerina Abigail Politi · Yale University · R01 · FY2020 · CA
Prospective study of cutaneous viral infections and non-melanoma skin cancer
$695,218Dana Elise Rollison · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
Probabilistic Multiscale Modeling of the Tumor Microenvironment
$695,214Wesley Tansey · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
$695,125Antonio M Omuro · Yale University · R01 · FY2022 · CA
Structural Biology of GTPase Activating Proteins
$694,910Robert Byrd · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mechanism-informed identification of causal enhancer variants
$694,900Emma Kirsten Farley · University Of California, San Diego · R01 · FY2025 · HG
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
$694,705Mount Sinai Medical Center (Miami Beach) · U10 · FY2002 · CA
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
$694,227Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA